Menopause is defined retrospectively — twelve consecutive months without a period. The transition leading to it, perimenopause, can begin years earlier and commonly lasts several years.
That transition period is where most symptoms occur, and it's the part least discussed. A great many women experience symptoms without connecting them to hormonal change, and receive investigations for other things instead.
What's happening physiologically
Ovarian function declines, and it declines erratically rather than smoothly.
Oestrogen levels fluctuate considerably, sometimes reaching higher peaks than in earlier reproductive years before falling. Progesterone declines as ovulation becomes less frequent.
That fluctuation, rather than the eventual low level, is thought to drive many of the symptoms. Which explains why testing hormone levels during perimenopause is frequently unhelpful — a single measurement captures a moment in a highly variable pattern and can appear entirely normal.
Diagnosis is generally clinical, based on age, symptoms and menstrual changes, rather than on blood tests. That surprises people who expect a definitive test.
The symptoms beyond the obvious
Hot flushes and night sweats are the recognised symptoms. The list is considerably longer and the less-known ones are where confusion arises.
Sleep disturbance, sometimes independent of night sweats.
Mood changes — anxiety, low mood, irritability, and for some women a marked increase in emotional volatility. Women with a history of premenstrual mood symptoms or postnatal depression appear to be at higher risk.
Cognitive symptoms — difficulty with word finding, concentration and memory. This is a genuinely reported phenomenon that causes considerable distress, with women frequently worried they're developing dementia. Available evidence suggests these changes are generally transient.
Joint and muscle aches, which are common and rarely attributed correctly.
Genitourinary symptoms — vaginal dryness, discomfort during sex, urinary urgency and recurrent urinary infections. Unlike hot flushes, these tend to progress rather than resolve, and they respond well to treatment.
Palpitations, headaches, changes in skin and hair, altered body composition.
Heavier or irregular periods before they stop, which can be substantial enough to cause anaemia.
Why it gets missed
Several reasons compound.
The age range overlaps with a period of life containing many other plausible explanations — work pressure, caring responsibilities, ageing parents, adolescent children. Symptoms get attributed to circumstances.
Presentation is variable enough that no two experiences look alike, so pattern recognition is harder.
And medical education on menopause has historically been limited, with surveys of both doctors and patients repeatedly finding gaps in knowledge and confidence.
The result is women receiving antidepressants for mood symptoms, investigations for palpitations, and referrals for joint pain, without the hormonal transition being considered.
Hormone therapy, and the confusion around it
This deserves careful handling because the history has produced lasting confusion.
Early results from a large trial in the early 2000s were widely reported as showing serious risks from hormone therapy, and prescribing fell dramatically worldwide.
Subsequent analysis has substantially refined that picture. Risk profiles differ considerably by age at initiation, by time since menopause, by type of hormone, and by route of administration. The population studied in that trial was older than the population typically starting treatment for symptoms.
Current guidance from menopause societies generally holds that for most healthy women under 60 or within ten years of menopause, with troublesome symptoms, the benefits outweigh the risks — with individual assessment required, and with specific contraindications for some women.
Risk does exist and varies by preparation. Transdermal oestrogen appears to carry lower thrombotic risk than oral. Combined preparations and oestrogen-only differ in their risk profiles. Breast cancer risk associations vary by regimen and duration.
This is genuinely a decision requiring individual discussion, and the point here is only that a blanket belief that it's dangerous doesn't reflect current understanding.
Other options
For women who cannot or prefer not to use hormone therapy, several approaches have evidence.
Non-hormonal medications for hot flushes exist, including some newer agents developed specifically for this.
Cognitive behavioural therapy has evidence for hot flush bother, sleep and mood, and is recommended in several guidelines.
Vaginal oestrogen for genitourinary symptoms is a low-dose local treatment with minimal systemic absorption, and it's frequently appropriate even for women who avoid systemic therapy.
Regarding supplements and botanical products, evidence is generally weak and inconsistent, and product quality varies.
What would help most
Better information, earlier. A great deal of the distress comes from not knowing what's happening and assuming something is seriously wrong.
Knowing that this is a transition with a name, an explanation and treatment options changes the experience substantially, even before any treatment is started.
If any of this is familiar, it's worth raising specifically — mentioning perimenopause by name — because that framing shifts the conversation more reliably than presenting individual symptoms separately.
General information only. Menopause management should be discussed with a qualified healthcare professional who can assess your individual circumstances.